Entrada Therapeutics Inc (TRDA) Live Share Price, Invest From India

Entrada Therapeutics Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

Day's Low
$13.11
Day's Price Range
$14.56
$14.56
9.96%
Downside
52 Week's Low
$4.93
52-Week Price Range
$14.56
$14.56
66.14%
Downside

Entrada Therapeutics Inc share price movements today

Previous Close: $13.50
Open: $13.46
Volume: 407.7K
Day's Low - High: $13.11 - $14.56
52 Week Low - High: $4.93 - $14.56

Entrada Therapeutics Inc Historical Returns

1 Month Return: + 10.27 %
3 Month Return: + 22.36 %
1 Year Return: + 57.1 %
3 Year Return: + 21.14 %
5 Year Return: 0 %

Entrada Therapeutics Inc Stock Fundamentals & Key Indicators

Check Entrada Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$524.1M

EPS (TTM)

-3.8871

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-151.9M

Revenue (TTM)

25.4M

Profit Margin

0.00%

Return On Equity TTM

-39.13%

Entrada Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Entrada Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Entrada Therapeutics Inc	BUY	$524.1M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Stock Returns calculator for Entrada Therapeutics Inc Stock including INR - Dollar returns

The Entrada Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Entrada Therapeutics Inc investment value today

Current value as on today

₹1,77,125

Returns

₹77,125

(+77.12%)

Returns from Entrada Therapeutics Inc Stock

₹57,746 (+57.75%)

Dollar Impact

₹19,378 (+19.38%)

Analyst Recommendation on Entrada Therapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Entrada Therapeutics Inc. Average target price of $21.4

Entrada Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Entrada Therapeutics Inc.

What analysts predicted

31.96%UPSIDE

Target Price

$21.4

Current Price

$14.56

Analyzed by

10 Analysts

Target

$21.40

Entrada Therapeutics Inc target price $21.4, a slight upside of 31.96% compared to current price of $14.56. According to 10 analysts rating.

Entrada Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Entrada Therapeutics Inc Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 3, 2026 to May 3, 2026

Change:64% versus previous 30 day period

Entrada Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	43	41	59	94	19	37	20	1	1	1
Gross Profit	21	41	59	94	19	37	20	1	-36	0
Operating Income	14	4	21	53	-21	-5	-21	-46	-47	-42
EBITDA	14	5	22	54	-20	-4	-20	-45	-42	-41
Interest Expense	-	4	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	1	1	0
Income Before Tax	52	9	25	57	-15	0	-17	-42	-43	-39
Income Tax Expense	17	18	1	2	-1	-1	-	0	0	0
Net Income	35	-9	23	55	-14	1	-17	-43	-44	-39
Net Profit Margin	81.08%	-22.81%	39.74%	58.11%	-71.70%	3.02%	-84.39%	-2210.41%	-2734.45%	-3014.93%

Entrada Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	25	129	210	25
Gross Profit	0	0	-1	-1	129	210	21
Operating Income	-11	-26	-51	-97	-3	47	-155
EBITDA	-11	-26	-50	-95	0	50	-142
Interest Expense	-	-	0	2	-	-	-
Depreciation	0	0	1	1	2	3	4
Income Before Tax	-5	-26	-51	-94	12	66	-142
Income Tax Expense	0	0	-1	-7	18	0	0
Net Income	-4	-26	-50	-87	-6	65	-143
Net Profit Margin	0.00%	0.00%	0.00%	-346.23%	-5.18%	31.13%	-565.48%

Entrada Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-9	23	55	-14	1	-17	-43	-44	-39
Operating Cash Flow	-4	-25	39	-24	-31	-38	-29	-28	-32
Investing Cash Flow	19	26	-24	-82	53	4	33	49	29
Financing Cash Flow	0	0	101	0	1	0	0	0	0
Change in Cash	15	0	116	-107	23	-33	4	20	-2

Entrada Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-26	-51	-94	-6	65	-143
Operating Cash Flow	-25	-50	-93	139	-41	-128
Investing Cash Flow	-2	-4	-148	-138	-27	116
Financing Cash Flow	50	307	0	21	102	0
Change in Cash	22	252	-245	22	33	-10

Global Institutional Holdings in Entrada Therapeutics Inc

Funds	Holdings
5AM Venture Management, LLC	10.6%
TCG Crossover Management, LLC	5.46%
Geode Capital Management, LLC	1.67%
Renaissance Technologies Corp	1%
Geode Capital Management, LLC	1.69%

See all

Insights on Entrada Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TRDA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, TRDA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, TRDA stock has moved up by 14.8%

About Entrada Therapeutics Inc

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Organisation	Entrada Therapeutics Inc
Headquarters	One Design Center Place, Boston, MA, United States, 02210
Industry	Biotechnology
CEO	Mr. Dipal Doshi
E-voting on shares	Click here to vote

Key Management of Entrada Therapeutics Inc

Name	Title
Mr. Dipal Doshi	CEO & Director
Mr. Nathan J. Dowden	President & COO
Dr. Natarajan Sethuraman Ph.D.	President of Research & Development
Dr. Jared Cohen J.D., Ph.D.	General Counsel

FAQs

What is Entrada Therapeutics Inc share price today?

Entrada Therapeutics Inc share price today is $14.56 as on May 2, 2026 at 1:29 am IST at the close of the market. Entrada Therapeutics Inc share today touched a day high of $14.56 and a low of $13.11.

What is the 52 week high and 52 week low for Entrada Therapeutics Inc share?

Entrada Therapeutics Inc share touched a 52 week high of $14.56 on May 1, 2026 and a 52 week low of $4.93 on August 11, 2025. Entrada Therapeutics Inc stock price today i.e. May 2, 2026 at 1:29 am IST is closed at $14.56,which is 0.00% down from its 52 week high and 195.33% up from its 52 week low.

What is Entrada Therapeutics Inc's market capitalisation today?

Entrada Therapeutics Inc market capitalisation is $0.00T as on May 2, 2026 at 1:29 am IST.

How to invest in Entrada Therapeutics Inc Stock (TRDA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Entrada Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entrada Therapeutics Inc Shares that will get you 0.1030 shares as per Entrada Therapeutics Inc share price of $14.56 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Entrada Therapeutics Inc Stock (TRDA) from India?

Indian investors can start investing in Entrada Therapeutics Inc (TRDA) shares with as little as ₹94.91 or $1 (as of May 3, 2026 at 11:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Entrada Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 3, 2026 at 11:40 am IST). Based on Entrada Therapeutics Inc share’s latest price of $14.56 as on May 2, 2026 at 1:29 am IST, you will get 0.6868 shares of Entrada Therapeutics Inc. Learn more about fractional shares .